基蛋生物 (603387.SH) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	1.1B	1.1B	1.2B	1.4B	1.8B
Cost of Revenue	341.3M	317.7M	358.4M	460.5M	636.4M
Gross Profit	733.8M	734.0M	806.4M	908.7M	1.2B
Operating Expenses
R&D Expense	155.3M	157.4M	181.2M	218.0M	223.2M
SG&A Expense	—	—	—	—	—
General & Admin Expense	94.2M	91.4M	95.7M	106.8M	103.9M
Selling & Marketing Expense	226.7M	231.1M	275.9M	333.0M	303.3M
Other Expenses	—	—	—	—	—
Total Operating Expenses	479.8M	479.7M	531.8M	621.3M	617.4M
Cost and Expenses	821.0M	797.4M	890.3M	1.1B	1.3B
Operating Income (EBIT)	243.0M	231.0M	258.1M	306.6M	563.3M
Non-Operating
Interest Income	—	—	—	—	—
Interest Expense	—	—	—	—	—
Net Interest Income	—	—	—	—	—
Other Non-Op Income/Expense	—	—	—	—	—
Non-Operating Income (excl Interest)	—	—	—	—	—
EBT (Pre-Tax Income)	241.0M	227.7M	253.4M	304.9M	560.0M
Income Tax Expense	18.2M	15.8M	23.6M	20.9M	56.0M
Bottom Line
Net Income	232.7M	220.7M	223.6M	279.8M	498.9M
Earnings from Cont. Ops	222.9M	211.9M	229.9M	284.1M	503.9M
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	232.7M	220.7M	223.6M	279.8M	498.9M
Per Share
Basic EPS	CN¥0.46	CN¥0.44	CN¥0.44	CN¥0.55	CN¥0.98
Diluted EPS	CN¥0.46	CN¥0.44	CN¥0.44	CN¥0.55	CN¥0.98
Revenue Per Share	CN¥2.11	CN¥2.10	CN¥2.29	CN¥2.69	CN¥3.58
Shares
Basic Shares Outstanding	508.7M	501.5M	508.3M	508.7M	509.1M
Diluted Shares Outstanding	508.7M	501.5M	508.3M	508.7M	509.1M
Profitability Metrics
EBITDA	—	318.7M	351.1M	400.8M	636.0M
D&A	—	87.6M	93.0M	94.3M	72.7M
EBIT	—	—	—	—	—

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026